[Enzymes of estrogen metabolism in breast cancer and their correlation with outcome].
The biopsy samples of 85 patients with breast cancer (BC) stage T1-3N0-3M0 were studied for estrogen metabolism enzymes (aromatase, 2,4-estrogene hydroxylase and gluthathion transferase) activity. This data was analyzed in relation to disease outcome. Aromatase activity in cancer tissue less than 20 fmol/ mg protein/h and 2,4-estrogene hydroxylase activity more than 230 pmol/mg protein/h proved to be the independent and significant predictors associated with worse relapse-free survival. The activity of gluthathiontransferase in tumor tissue less than 40 mkmol/mg protein/h is associated with worse metastatic-free survival. The activities of estrogen metabolism enzymes may be used as additional prognostic markers for breast cancer outcome.